The positive news just continues. They just beat their forecast of $5.7-$6.2 mill by recording a NPAT of $6.467mill. Their second half eps=0.032c. Annualise that and you get 0.064c. This puts them on a pe of just 10.88 (at a closing price of 69c).
Given it is the health sector, this company could easily justify a pe=15 or a price of 95c.
Disclaimer. Still holding
Bookmarks